List of Tables
Table 1. Radiopharmaceutical Theranostics Market Trends
Table 2. Radiopharmaceutical Theranostics Market Drivers & Opportunity
Table 3. Radiopharmaceutical Theranostics Market Challenges
Table 4. Radiopharmaceutical Theranostics Market Restraints
Table 5. Global Radiopharmaceutical Theranostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Radiopharmaceutical Theranostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Radiopharmaceutical Theranostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Radiopharmaceutical Theranostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Radiopharmaceutical Theranostics
Table 10. Global Radiopharmaceutical Theranostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Theranostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Radiopharmaceutical Theranostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Radiopharmaceutical Theranostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Radiopharmaceutical Theranostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Radiopharmaceutical Theranostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Radiopharmaceutical Theranostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Radiopharmaceutical Theranostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Radiopharmaceutical Theranostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Radiopharmaceutical Theranostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Radiopharmaceutical Theranostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Radiopharmaceutical Theranostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Radiopharmaceutical Theranostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Radiopharmaceutical Theranostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Radiopharmaceutical Theranostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Radiopharmaceutical Theranostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Radiopharmaceutical Theranostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Radiopharmaceutical Theranostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Radiopharmaceutical Theranostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Radiopharmaceutical Theranostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Nihon Medi-Physics Basic Information List
Table 32. Nihon Medi-Physics Description and Business Overview
Table 33. Nihon Medi-Physics Radiopharmaceutical Theranostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Nihon Medi-Physics (2019-2024)
Table 35. Nihon Medi-Physics Recent Developments
Table 36. ITM Isotopen Technologien München AG Basic Information List
Table 37. ITM Isotopen Technologien München AG Description and Business Overview
Table 38. ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of ITM Isotopen Technologien München AG (2019-2024)
Table 40. ITM Isotopen Technologien München AG Recent Developments
Table 41. Advanced Accelerator Applications Basic Information List
Table 42. Advanced Accelerator Applications Description and Business Overview
Table 43. Advanced Accelerator Applications Radiopharmaceutical Theranostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Advanced Accelerator Applications (2019-2024)
Table 45. Advanced Accelerator Applications Recent Developments
Table 46. Telix Pharmaceuticals Basic Information List
Table 47. Telix Pharmaceuticals Description and Business Overview
Table 48. Telix Pharmaceuticals Radiopharmaceutical Theranostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Telix Pharmaceuticals (2019-2024)
Table 50. Telix Pharmaceuticals Recent Developments
Table 51. GE Healthcare Basic Information List
Table 52. GE Healthcare Description and Business Overview
Table 53. GE Healthcare Radiopharmaceutical Theranostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of GE Healthcare (2019-2024)
Table 55. GE Healthcare Recent Developments
Table 56. Theragnostics Ltd. Basic Information List
Table 57. Theragnostics Ltd. Description and Business Overview
Table 58. Theragnostics Ltd. Radiopharmaceutical Theranostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Theragnostics Ltd. (2019-2024)
Table 60. Theragnostics Ltd. Recent Developments
Table 61. NuView Life Sciences Basic Information List
Table 62. NuView Life Sciences Description and Business Overview
Table 63. NuView Life Sciences Radiopharmaceutical Theranostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of NuView Life Sciences (2019-2024)
Table 65. NuView Life Sciences Recent Developments
Table 66. Jubilant Pharma Limited Basic Information List
Table 67. Jubilant Pharma Limited Description and Business Overview
Table 68. Jubilant Pharma Limited Radiopharmaceutical Theranostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Jubilant Pharma Limited (2019-2024)
Table 70. Jubilant Pharma Limited Recent Developments
Table 71. Lantheus Holdings, Inc. Basic Information List
Table 72. Lantheus Holdings, Inc. Description and Business Overview
Table 73. Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Lantheus Holdings, Inc. (2019-2024)
Table 75. Lantheus Holdings, Inc. Recent Developments
Table 76. Curium Pharma Basic Information List
Table 77. Curium Pharma Description and Business Overview
Table 78. Curium Pharma Radiopharmaceutical Theranostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Curium Pharma (2019-2024)
Table 80. Curium Pharma Recent Developments
Table 81. Bayer AG Basic Information List
Table 82. Bayer AG Description and Business Overview
Table 83. Bayer AG Radiopharmaceutical Theranostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Bayer AG (2019-2024)
Table 85. Bayer AG Recent Developments
Table 86. Clarity Pharmaceuticals Basic Information List
Table 87. Clarity Pharmaceuticals Description and Business Overview
Table 88. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Radiopharmaceutical Theranostics Business of Clarity Pharmaceuticals (2019-2024)
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Radiopharmaceutical Theranostics Downstream Customers
Table 94. Radiopharmaceutical Theranostics Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Radiopharmaceutical Theranostics Product Picture
Figure 2. Global Radiopharmaceutical Theranostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Radiopharmaceutical Theranostics Report Years Considered
Figure 5. Global Radiopharmaceutical Theranostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Theranostics Revenue in 2023
Figure 7. Radiopharmaceutical Theranostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Oncology Picture
Figure 9. Cardiology Picture
Figure 10. Others Picture
Figure 11. Global Radiopharmaceutical Theranostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Radiopharmaceutical Theranostics Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Academic & Research Institutes
Figure 15. Product Picture of Others
Figure 16. Global Radiopharmaceutical Theranostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Radiopharmaceutical Theranostics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Radiopharmaceutical Theranostics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Radiopharmaceutical Theranostics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Radiopharmaceutical Theranostics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Radiopharmaceutical Theranostics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Radiopharmaceutical Theranostics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Radiopharmaceutical Theranostics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Radiopharmaceutical Theranostics Sales Value (%), (2019-2030)
Figure 29. United States Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Radiopharmaceutical Theranostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Radiopharmaceutical Theranostics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Radiopharmaceutical Theranostics Sales Value by Application (%), 2023 VS 2030
Figure 50. Radiopharmaceutical Theranostics Industrial Chain
Figure 51. Radiopharmaceutical Theranostics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
